Find Faculty
Home>Education and Training>Graduate Medical Education>Fellowship Programs>Combined RUMC and CCH Infectious Diseases Fellowship
Menu

Welcome to our Infectious Diseases Fellowship Website

Apply Now

The combined Rush University Medical Center (RUMC) and Cook County Health (CCH) Infectious Diseases Fellowship Program provides a two-year curriculum with an optional third year of training that is dedicated to training successful Infectious Diseases physicians with the essential building blocks for any desired career path in the field. We have more than 40 faculty who specialize in 12 areas of divisional expertise and are world leaders in HIV and healthcare epidemiology research. Situated in the amazing city of Chicago, fellows can enjoy all of our program advantages and explore all that the city has to offer.

Thank you for your interest in our program!

 

A Message from the Chiefs

A brief message from the Infectious Disease Chief Fellows for the year 2021-2022, Dr. Haseeba Khan and Dr. Hina Farooq.

 

Rush
RUSH Goes Social!
We are excited to announce the expansion of our social media presence with the launch of our official Twitter (@RushCCH_ID) and Instagram (@rushcchid) accounts! Be sure to follow us to stay up-to-date on our fellowship program.
Chicago and Rush Partner to Detect New Strains of COVID-19
In collaboration with CDPH, Rush University Medical Center opens the new Regional Innovative Public Health Laboratory to identify unique strains of COVID-19 in Chicago. Read more…
Faculty Accomplishments
Congratulations to Dr. Shivanjali Shankaran for receiving this year’s Rush Department of Internal Medicine Attending Teaching Award! We are proud and honored to have such an astounding physician-educator as part of our division.
 
Do Young Kim
Fellow Accomplishments
Our 3rd year fellow, Dr. Do Young Kim, was awarded one of four 2020-2021 CDC sponsored LEAP fellowships, and is the lead investigator in the CLEARANCE study. In collaboration with CDPH, Dr. Kim has participated in multiple public health guidance updates, communicable diseases outbreaks, and is leading the Chicago COVID-19 re-infection project.
 
We welcome our new Infectious Disease Fellows!

We are thrilled and excited for July 1st when we welcome the new fellows to the RUSH/CCH ID family! As we welcome the 2021 class, we will say farewell to our graduating fellows with a fun-filled evening at Enoteca Roma Ristorante before they embark on their next professional chapter.

Hemil Gonzalez, MDFellows Accomplishments

During his fellowship, Dr. Hemil Gonzalez received a 2019-2021 ACTG Minority HIV Investigator Mentoring Program award which allowed him to pursue his passion for HIV research as a 3rd-year research fellow. His work has been published in the Journal of Neuroimmune Pharmacology and the Journal of Sexually Transmitted Diseases.

Mary HaydenFaculty Accomplishments
Congratulations to Dr. Mary Hayden for her appointment as president for The Society of Healthcare Epidemiology of America (SHEA) Board of Trustees, where she continues to serve as a national leader in healthcare epidemiology and antibiotic stewardship.
IDWeek 2020
Despite the COVID-19 pandemic forcing IDWeek to go virtual, our second-year fellows had the opportunity to participate in the 2020 annual conference and learn from internationally recognized experts in the field of infectious diseases and interact with other aspiring infectious diseases professionals.
 
Weinstein IDWeek 2019CONGRATULATIONS TO…
Dr. Robert A. Weinstein, Professor of Internal Medicine, Division of Infectious Diseases at RUMC and Chairman Emiratus at CCH, on receiving the prestigious SHEA Senior Scholarship Award at the IDWeek 2019.

Recent Publications:

  • Sansom SE, Logan LK, Green SJ, Moore NM, Hayden MK. Whole-genome sequencing for neonatal intensive care unit outbreak investigations: Insight and lessons learned. Antimicrobial Stewardship & Healthcare Epidemiology 2021;1(1), E2. doi:10.1017/ash.2021.161
  • Gottlieb M, Sansom SE, Frankenberger C, Ward EJ, Hota B. Clinical Course and Factors Associated with Hospitalization and Critical Illness Among COVID-19 Patients in Chicago, Illinois. Academic Emergency Medicine 2020. 2020;27(10):963-973. PMID: 32762106

Recent Presentations:

  • Sansom SE, Lin M, Schoeny M, Fukuda C, Shimasaki T, Dangana T, Moore N, Yelin R, Rhee Y, Tabith L, Sheng J, Cornejo Cisneros E, Murray J, Chang K, Lolans K, Ariston M, Rotunno W, Ramos H, Li H, Aboushaala K, Iwai N, Bassis B, Bell P, Young V, Hayden MK, for the CDC Prevention Epicenters Program. Admission and Discharge Sampling Underestimates Multidrug-Resistant Organisms (MDRO) Acquisitions in an Intensive Care Unit. SHEA Spring 2021. April 16, 2021. 
  • SHEA Spring 2021. “SHEA’s Role in Leadership during COVID-19.” Virtual conference, April 13-16, 2021. Invited opening plenary speaker. 
  • 6th International Conference on Healthcare Associated Infections: Decennial Day. “Attacking healthcare transmission of AMR on multiple fronts: antibiotics, the microbiome, and containment.” Virtual conference, April 12, 2021. Invited symposium speaker.
  • IDWeek 2020, Virtual. Symposium, October 21-25, 2020. “Candida auris in the long-term care setting.”
  • Sansom SE, Lin MY, Schoeny M, Bassis CM, Young VB, Fukuda C, Shimasaki T, Dangana T, Moore N, Yelin RD, Liu S, Rhee Y, Tabith L, Sheng J, Cornejo Cisneros E, Murray J, Chang K, Lolans K, Ariston M, Rotunno W, Ramos H, Li H, Aboushaala K, Iwai N, Hayden MK, for The CDC Prevention Epicenters Program. Understanding intermittent detenction of multidrug-resistant organisms (MDROs) in rectally colonized patients. IDSA ID Week 2020. October 2020. Philadelphia, PA. 

Oral Presentations:

  • Lin MY, Tang A, Fealy AE, Gao W, Markovski G, Xiang Y, Trick W. First five years of experience with the illinois extensively Drug resistant organism (XDRO) registry and implementation of automated alerting. Abstract no. 82, IDWeek 2019, Washington DC, October 2-6, 2019
  • McKinnell JA, Singh R, Miller LG, Saavedra R, Heim L, Gussin G, Lewis B, Estevez M, Catuna TD, Lee E, He J, Kleinman K, Shimabuduo J, Evans K, Bittencourt C, Baesu C, Gohil SK, Park S, Tam S, Robinson PA, Slayton R, Stone ND, Jernigan JA, Zahn M, Janssen L, O’Donnell K, Weinstein RA, Hayden MK, lee BY, Mueller LE, Bartsch SM, Peterson EM, Huang SS. The SHIELD Orange County Project: A decolonization strategy in 35 hospitals and nursing homes reduces multi-drug resistant organisms (MDRO) prevalence in Southern California region. Abstract no. 893, IDWeek 2019, Washington DC, October 2-6, 2019
  • Rhee Y, Hayden MK, Simms AT, Yelin RD, Lolans K, Bell PB, Schoeny M, Baker AW, Gohil SK, Rhee C, Talati N, Warren DK, Welbel SF, Dangana TE, Bravo H, Cass C, Nelson A, Tolomeo PC, Wolf R, Lin MY. Impact of measurement and results feedback of chlorhexidine gluconate (CHG) skin concentrations in medical intensive care unit (MICU) patients receiving CHG bathing. Abstract no. 895, IDWeek 2019, Washington DC, October 2-6, 2019
  • Hayden MK, Dangana TE, Yelin RD, Schoeny M, Stanley M, Preite N, Kahn N, Edomwande O, Black SR, Pacilli M, Xin H, Deming C, Lin MY, Segre JA. Prevalence of Candida auris at body Sites, characterization of skin microbiota, and relation of chlorhexidine gluconate (CHG) skin concentration to C. auris detection among patients at a high-prevalence ventilator-capable skilled nursing facility (vSNF) with established CHG bathing. Abstract no. 87, IDWeek 2019, Washington DC, October 2-6, 2019
  • Huhn GD, Ramgopal M, Crofoot G, Gatje J, Seyedkazemi S, Cosler P, Simonson RB, Luo D, Dunn K. High rates of virological suppression achieved in HIV-1-infected adults rapidly starting antiretroviral therapy (ART) with the single-tablet regimen (STR) of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg regardless of baseline disease characteristics: Week 48 subgroup analysis from the phase 3 DIAMOND Trial. Abstract no. 887, IDWeek 2019, Washington DC, October 2-6, 2019
  • Bassis C, Seekatz A, Dangana TE, Shimasaki T, Yelin RD, Schoeny M, Rhee Y, Ariston M, Lolans K, Cornejo-Cisneros E, Aboushaala K, Thabit L, Murray J, Ollison S, Bell PB, Fogg L, Weinstein RA, Lin MY, Young VB, Hayden MK. Gut microbiota differenes at the time of medical intensive care unit (MICU) admission are associated with acquisition of multidrug-resistant organisms (MDRO) among patients not already colonized with a MDRO. Abstract no. 2849, IDWeek 2019, Washington DC, October 2-6, 2019

Poster Presentations:

  • Rhee Y, Hayden MK, Simms AT, Yelin RD, Lolans K, Bell PB, Schoeny M, Baker AWm Gohil SK, Rhee C, Talati NJ, Warren DK, Welbel SF, Dangana TE, Majalca T, Bravo H, Css C, Nelson A, Tolomeo PC, Wolf R, Lin MY. Relationship between chlorohexidine gluconate (CHG) skin concentrations and microbial skin colonization among medical intensive care units (MICU) patients. Abstract no. 572, IDWeek 2019, Washington DC, October 2-6, 2019
  • Young VB, Keidan M, Yelin RD,  Dangana TE, Bell PB, Rao K, Hayden MK. Shedding of viable Clostridioldes difficile in patients admitted to a medical intensive care unit. Abstract no. 2424, IDWeek 2019, Washington DC, October 2-6, 2019
  • Sansom S, Moore NM,  Kazi AS, Won SY. Effect of adjusted CLSI breakpoints on center-wide fluoroquinolone susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is it time to restrict empiric fluoroquinolone use? Abstract no. 2184, IDWeek 2019, Washington DC, October 2-6, 2019
  • Kazi AS, Sansom S, Varughese C, Hodgson  HA, Won SY. Love thy steward - who does not love antimicrobial stewardship. Abstract no. 1043, IDWeek 2019, Washington DC, October 2-6, 2019
  • Patel PV, Nash CB, Vu BN. Evaluation of neonatal sepsis guidelines in a neonatal intensive care unit. Abstract no. 1040, IDWeek 2019, Washington DC, October 2-6, 2019
  • Rynkiewich K, Schwartz D, Won SY, Heber M, Timmereddy K, Stoner B. An ethnographic approach to interrogating animicrobial stewardship at US teaching hospitals. Abstract no. 1091, IDWeek 2019, Washington DC, October 2-6, 2019
  • Rhee Y, Hayden MK, Simms AT, Yelin RD, Lolans K, Bell PB, Schoeny M, Baker AW, Baker MA, Hohil SK, Rhee C, Talati NJ, Warren DK, Welbel SF, Dangana TE, Majalca T, Bravo H, Cass C, Nelson A, Tolomeo PC, Wolf R, Lin MY. Relationship between chlorhexidine gluconate (CHG) skin concentration and microbial skin oolonization among medical intensive care unit. Abstract no. 572, IDWeek 2019, Washington DC, October 2-6, 2019
  • Medernach RL, Domitrovic TN, Hayani KC, Hujer AM, Qureshi NK, Marshall SH, Nguyen DC, Rudin SD, Rispens JR, Zheng X, Weinstein RA, Bonomo RA, Logan LK. Multi-centered study of the clinical and molecular epidemiology of AmpC cephalosporinase-producing Enterobacteriaceae infections in children. Abstract no. 594, IDWeek 2019, Washington DC, October 2-6, 2019
Faculty Accomplishments
Our RUMC/CCH faculty has successfully put together The Chicago Infectious Disease Board Review. Check out the link below for more information:
  ID Board Review Course

  Archived Announcements

 How to apply

Positions are currently available for five first-year fellows. Find full details and begin your application